Immunotherapy

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade
Lijun Xu, Bingyu Li, Chenyu Pi, Zhaohua Zhu, Fei Tao, Kun Xie, Yan Feng, Xiaoqing Xu, Yanxin Yin, Hua Gu, Jianmin Fang

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005447; DOI: 10.1136/jitc-2022-005447
Systemic cellular viroimmunotherapy for canine high-grade gliomas
Ana Cloquell, Isidro Mateo, Stefano Gambera, Martí Pumarola, Ramon Alemany, Javier García-Castro, Ana Judith Perisé-Barrios

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005669; DOI: 10.1136/jitc-2022-005669
MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy
Jiachen Wang, Zhen Shang, Jue Wang, Jinhuan Xu, Weigang Li, Yuqi Guan, Li Yang, Wei Zhang, Kefeng Shen, Meilan Zhang, Jin Wang, Liting Chen, Qinlu Li, Cheng He, Na Wang, Liang Huang, Yi Xiao, Min Xiao, Jianfeng Zhou

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002029; DOI: 10.1136/jitc-2020-002029
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1
Abbass Darwich, Alessandra Silvestri, Mohamed-Reda Benmebarek, Juliette Mouriès, Bruno Cadilha, Alessia Melacarne, Lapo Morelli, Domenico Supino, Alexandre Taleb, Hannah Obeck, Claudio Sustmann, Agnese Losurdo, Giovanna Masci, Giuseppe Curigliano, Sebastian Kobold, Giuseppe Penna, Maria Rescigno

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003224; DOI: 10.1136/jitc-2021-003224
GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
Guillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, Samantha N Buongervino, Amy K Erbe, Doncho V Zhelev, Shakhnozakhon Sadirova, Anna M Giudice, Daniel Martinez, Laura Garcia-Gerique, Dimiter S Dimitrov, Paul M Sondel, Kristopher R Bosse

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e004704; DOI: 10.1136/jitc-2022-004704
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group
Amy K Erbe, Mitch B Diccianni, Rajen Mody, Arlene Naranjo, Fan F Zhang, Jen Birstler, KyungMann Kim, Arika S Feils, Jung-Tung Hung, Wendy B London, Barry L Shulkin, Varsha Mathew, Marguerite T Parisi, Sabah Servaes, Shahab Asgharzadeh, John M Maris, Julie Park, Alice L Yu, Paul M Sondel, Rochelle Bagatell

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006530; DOI: 10.1136/jitc-2022-006530
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
Monika Joshi, Leonard Tuanquin, Junjia Zhu, Vonn Walter, Todd Schell, Matthew Kaag, Deepak Kilari, Jiangang Liao, Sheldon L Holder, Hamid Emamekhoo, Alexander Sankin, Suzzane Merrill, Hong Zheng, Joshua Warrick, Ralph Hauke, Benjamin Gartrel, Mark Stein, Joseph Drabick, David J Degraff, Yousef Zakharia

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006551; DOI: 10.1136/jitc-2022-006551
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
Iva Truxova, David Cibula, Radek Spisek, Jitka Fucikova

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e005968; DOI: 10.1136/jitc-2022-005968
Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data
WeiQing Venus So, David Dejardin, Eva Rossmann, Jehad Charo

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006464; DOI: 10.1136/jitc-2022-006464
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells
Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake, Satoshi Ishikawa, Atrayee Bhattacharya, Atsushi Fushimi, Rehan Ahmad, Hidekazu Takahashi, Olga Dashevsky, Constantine Mitsiades, Donald Kufe

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006238; DOI: 10.1136/jitc-2022-006238

Main menu

Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy

Pages